Paula N. Alves-Rodrigues
Ribeirao Preto, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells.
Journal: Signal transduction and targeted therapy
Published: March 22, 2019
IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells.
Journal: Cancer letters
Published: January 21, 2019
Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis.
Journal: Clinics (Sao Paulo, Brazil)
Published: January 10, 2018
Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms.
Journal: Cell death & disease
Published: May 02, 2017
IRS1/β-Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells.
Journal: Journal of cellular biochemistry
Published: August 23, 2016
Reversine triggers mitotic catastrophe and apoptosis in K562 cells.
Journal: Leukemia research
Published: January 06, 2016
Mantle cell lymphoma harboring Burkitt's-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities.
Journal: Medical oncology (Northwood, London, England)
Published: November 18, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026